New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 21, 2013
12:19 EDTWMT, KO, RPRX, PRKR, QCOM, PAY, RFMD, SWKSOn The Fly: Midday Wrap
Stocks on Wall Street were lower at midday following a number of domestic economic reports. The averages dipped at the outset in a continuation of yesterday’s moderate sell-off, though the market found a level about a half hour into the session and has been range bound since that point... ECONOMIC EVENTS: In the U.S., initial jobless claims rose 20K to 362K last week, coming in above the consensus forecast for 355K claims. The headline consumer price index was flat in January, versus expectations for 0.1% increase, while the "core" rate climbed 0.3%, which was above the 0.2% forecast. Markit's "flash" purchasing managers' index for the U.S. for February came in at 55.2, versus forecasts for a 55.5 first look for the month. The Philadelphia Fed Manufacturing survey fell to -12.5, versus expectations for it to rise to +1.0. Existing home sales for January increased 0.4% to a 4.92M pace, versus an expected decline of 0.8%. The leading economic indicators rose 0.2% to 94.1 in January, in line with expectations. In Europe, the composite services and manufacturing PMI for the shared currency nations fell to 47.3 in February from 48.6 in January, missing forecasts for an improved reading... COMPANY NEWS: Wal-Mart (WMT) confirmed its February sales started off weak, as leaked in internal emails reported by Bloomberg last week. The telegraphed bad start was reflected in the company’s worse than expected forecast for the coming quarter, but earnings in the holiday quarter that just ended beat consensus. The company raised its dividend by 18% as well and shares of the Dow member reacted favorably, rising about 2.5% to lead the DJIA... Coca-Cola (KO), another Dow component, also increased its dividend by 10%, though investor reaction was more muted. Coke shares were up fractionally in midday trading after the announcement... MAJOR MOVERS: Among the notable gainers were ParkerVision (PRKR), which jumped 37% after the company said it received favorable patent in patent claim construction ruling in a suit with Qualcomm (QCOM), and Repros Therapeutics (RPRX), which rose 32% after it said the FDA recommended it complete its study of Androxal. Among the noteworthy losers was VeriFone (PAY), which sank 39% after the company's preliminary Q1 results and preliminary Q2 guidance fell below expectations and the stock was downgraded by at least five firms. Also lower were shares of several semiconductor makers, including RF Micro Devices (RFMD) and Skyworks Solutions (SWKS), which fell following downgrades at Raymond James and the announcement of a new class of chips from Qualcomm... INDICES: Near noon, the Dow was down 59.72, or 0.43%, to 13,867.82; the Nasdaq was down 29.41, or 0.93%, to 3,135.00; and the S&P 500 was down 9.25, or 0.61%, to 1,502.70.
News For WMT;KO;RPRX;PRKR;QCOM;PAY;RFMD;SWKS From The Last 14 Days
Check below for free stories on WMT;KO;RPRX;PRKR;QCOM;PAY;RFMD;SWKS the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
September 5, 2014
08:21 EDTWMTWal-Mart seeks lower rent, more control with China mall, China Daily says
Subscribe for More Information
07:31 EDTQCOMNVIDIA lawsuit positive, says Stifel
Subscribe for More Information
07:30 EDTPAYApple iWallet would be positive for payment networks, says JPMorgan
Subscribe for More Information
06:00 EDTPAYVeriFone downgraded to Market Perform from Outperform at Raymond James
Raymond James downgraded VerFone to Market Perform due to valuation, ongoing reinvestments that limit upside profitability, and potentially peaking EMV demand at large customers.
September 4, 2014
16:13 EDTQCOMNVIDIA files patent infringement complaint against Qualcomm, Samsung
Subscribe for More Information
10:59 EDTPAYOptions with decreasing implied volatility
Options with decreasing implied volatility: BIG GES CONN PAY ANF CIEN SPLK OVTI WDAY NAV
09:06 EDTPAYOn The Fly: Pre-market Movers
UP AFTER EARNINGS: PVH Corp. (PVH), up 9%... Verifone (PAY), up 3.8%... Methode Electronics (MEI), up 13%... Bazaarvoice (BV), up 9%. ALSO HIGHER: Bolt Technology (BOLT), up 35.7% after Teledyne (TDY) agrees to acquire the company for $22 per share in cash... Mitek Systems (MITK), up 58% after USAA lawsuit settlement... Tibco Software (TIBX), up 7% after announcing that it is reviewing strategic alternatives... Stereotaxis (STXS), up 22% after receiving FDA clearance for Vdrive with V-Loop system... NewLink (NLNK), up 3.4% after reporting FDA approval for Phase 1 clinical studies of Ebola vaccine. DOWN AFTER EARNINGS: Ciena (CIEN), down 3%... Joy Global (JOY), down 1%... Matrix Service (MTRX), down 11%... Mobileye (MBLY), down 1.3%. ALSO LOWER: Yum! Brands (YUM), down 2.8% after updating third quarter China division same-store sales guidance... 3D Systems (DDD), down 2.9% after downgraded at Pacific Crest... GoPro (GPRO), down 3.5% after downgraded at JPMorgan... Shanda Games (GAME), down 4% after announcing reconstitution of special committee.
07:45 EDTKOCoca-Cola can continue to outperform, says Bernstein
Subscribe for More Information
07:36 EDTRPRXRepros Therapeutics weakness a buying opportunity, says Brean Capital
Brean Capital said the recent weakness in Repros Therapeutics is a buying opportunity. The firm said concerns over the upcoming FDA meeting are overblown and shares were substantially oversold in response to negative commentary yesterday. Shares of Repros Therapeutics remain Buy rated with a $41 price target.
07:36 EDTPAYVeriFone ups FY14 EPS view to $1.46-$1.47, consensus $1.45
Subscribe for More Information
07:35 EDTPAYVeriFone sees Q4 EPS 39c-40c, consensus 42c
Subscribe for More Information
07:34 EDTPAYVeriFone reports Q3 EPS 40c, consensus 35c
Subscribe for More Information
September 3, 2014
16:20 EDTRPRXOn The Fly: Closing Wrap
Stocks on Wall Street began the session in positive territory after Russian President Vladimir Putin said he had an outline for a cease-fire plan for eastern Ukraine and was closing in an agreement. The averages hit their highs shortly after the open and the Nasdaq was the first index to cross into negative territory as it was weighed down by Apple's (AAPL) decline. The market moved in a narrow range as investors anticipated the Fed’s Beige Book report, scheduled for release mid-afternoon. The report was fairly benign and the market limped into the close, with volume remaining light. ECONOMIC EVENTS: U.S. factory orders rose 10.5% in July, which was a bit below the forecast for 11.0% growth. The Fed's Beige Book stated that the pace of growth did not change significantly in any of the central bank's 12 regions during a six week period ended in August compared with the previous six week period. COMPANY NEWS: Shares of Apple retreated $4.36, or 4.22%, to $98.94 after research firm Pacific Crest advised investors to take some profits in the stock. Analyst Andy Hargreaves forecast the percentage of new iPhone users who buy the next version of the device beyond the iPhone 6 is likely to decline versus prior cycles. The stock likely has only limited room to increase, according to Hargreaves, who said he would probably downgrade Apple unless new products that can generate billions of dollars in new operating profit are launched at its September 9 event. MAJOR MOVERS: Among the notable gainers was Infinity Pharmaceuticals (INFI), which surged $4.81, or 44.05%, to $15.73 after the company announced a cancer drug collaboration with AbbVie (ABBV) and a master clinical supply agreement with Roche (RHHBY). Also higher was Mobileye (MBLY), which jumped $3.94, or 9.16%, to $46.97 ahead of its second quarter earnings report, which is due tomorrow morning. Among the noteworthy losers was Repros Therapeutics (RPRX), which fell $4.11, or 18.55%, to $18.05 after FDA briefing documents ahead of a panel on T-normalizing therapies prompted Piper Jaffray to downgrade the stock to Neutral from Overweight. Also lower after its earnings report was apparel company Vince Holding (VNCE), which fell $4.47, or 11.54%, to $34.27. Analysts at Piper Jaffray attributed the post-earnings weakness to investor concerns over heightened inventory levels, but the firm said it still sees Vince as one of the best small cap growth names in its space and would be "aggressive buyers" on the weakness. INDEXES: The Dow edged up 10.72, or 0.06%, to 17,078.28, the Nasdaq fell 25.62, or 0.56%, to 4,572.56, and the S&P 500 slipped 1.56, or 0.08%, to 2,000.72.
15:29 EDTPAYNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's market open, with earnings consensus, include Joy Global (JOY), consensus 84c; VeriFone Systems (PAY), consensus 35c; Ciena (CIEN), consensus 29c; Mattress Firm (MFRM), consensus 60c; Methode Electronics (MEI), consensus 40c; UTi Worldwide (UTIW), consensus 1c.
12:33 EDTRPRXOn The Fly: Midday Wrap
Stocks on Wall Street were higher to begin the day, as reports spurred optimism that a ceasefire agreement between Russia and the Ukraine may soon be reached. The move was short lived, as the averages turned mixed during the second hour of trading. Shares of Apple (AAPL) are weighing down the Nasdaq after an analyst recommended investors take some profits in the stock. ECONOMIC EVENTS: In the U.S., factory orders rose 10.5% in July, which was a bit below the forecast for 11.0% growth. The Fed's Beige Book is scheduled to be released at 2:00 pm ET. In Europe, the final reading of Eurozone services PMI was knocked down to 53.1 from a preliminary 53.5 reading, mirroring the lowering of the Eurozone manufacturing PMI reading yesterday. COMPANY NEWS: Shares of Apple retreated 4% after research firm Pacific Crest advised investors to take some profits in the stock. Pacific Crest analyst Andy Hargreaves forecast the percentage of new iPhone users who buy the next version of the device beyond the iPhone 6 is likely to decline versus prior cycles. The stock likely has only limited room to increase, according to Hargreaves, who said he would probably downgrade Apple unless new products that can generate billions of dollars in new operating profit are launched at its September 9 event... Carmakers reported on August vehicle sales in the U.S., with Chrysler (FIATY) reporting a 20% increase, Ford stating that sales rose slightly compared to the prior year and General Motors (GM) posting a 1.2% decline in sales. MAJOR MOVERS: Among the notable gainers was Infinity Pharmaceuticals (INFI), which jumped 46% after the company announced a cancer drug collaboration with AbbVie (ABBV) and a master clinical supply agreement with Roche (RHHBY). Also higher was Mobileye (MBLY), which gained nearly 10% after Morgan Stanley wrote that the stock could rise "towards $100" if the company maintains its current market, gross margins and earnings position. Mobileye is scheduled to report on its second quarter results tomorrow morning, which will be its first quarterly report since its August IPO. Among the noteworthy losers was Repros Therapeutics (RPRX), which dropped 15% after newly posted FDA briefing documents regarding a panel on T-normalizing therapies prompted Piper Jaffray to downgrade the stock to Neutral from Overweight. Also lower following its earnings report was apparel company Vince Holding (VNCE), which fell 11%. INDEXES: Near midday, the Dow was up 33.71, or 0.2%, to 17,101.27, the Nasdaq was down 23.24, or 0.51%, to 4,574.95, and the S&P 500 was down 0.64, or 0.03%, to 2,001.64.
11:42 EDTWMTWal-Mart de Mexico scales back 2014 store expansion plans, WSJ says
Subscribe for More Information
11:13 EDTRPRXRepros Therapeutics downgraded to Neutral at Piper Jaffray
Subscribe for More Information
11:09 EDTRPRXRepros Therapeutics downgraded to Neutral from Overweight at Piper Jaffray
Subscribe for More Information
09:01 EDTKOKeurig Green Mountain, Coca-Cola expand agreement to Keurig hot brewing system
Keurig Green Mountain (GMCR) and The Coca Cola Company (KO) have expanded the companies’ innovative partnership to offer select beverages from the portfolio of The Coca Cola Company’s still brands in the Keurig hot brewing system in the United States and Canada. Honest Tea will be the first brand from The Coca Cola Company available in K-Cup® packs. In February 2014, the companies signed a 10-year agreement to collaborate on the development and introduction of The Coca Cola Company's global brand portfolio for use in Keurig’s forthcoming Keurig Cold™ at-home beverage system, available in Keurig’s fiscal year 2015. As part of that agreement Coca-Cola acquired a 10% minority equity position in Keurig and subsequently announced its intention to increase its stake up to 16%.
07:38 EDTPAYVeriFone Q3 results could bring another guidance raise, says Jefferies
Jefferies does not think expectations are too high into VeriFone's Q3 results tomorrow. The firm believes another FY14 guidance hike is possible, and that a beat and raise quarter would be positive for shares. Jefferies says the upside potential in Q3 is unlikely to be as big as Q2. It keeps a Buy rating on VeriFone with a $42 price target.
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use